Genentech is months away from starting operations at a new $240 million pharmaceutical-fill/finish plant it recently built in Hillsboro, Ore., designed to accommodate its needs and those of its partner-turned-acquirer, Roche.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.
In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.
South African researchers uncover bone cancer in an ancient hominin ancestor.
English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.